TY - JOUR
T1 - Moving the dial on diagnostics
T2 - an update from the Lancet Commission on diagnostics
AU - Horton, Susan
AU - Wilson, Michael L.
AU - Cheung, Annie N.Y.
AU - DeStigter, Kristen
AU - Kohli, Mikashmi
AU - Sayed, Shahin
AU - Schroeder, Lee F.
AU - Sullivan, Richard
AU - Tan, Bien Soo
AU - Alooh, Millicent
AU - Dahn, Bernice
AU - Donoso-Bach, Lluis
AU - Garcia, Patricia J.
AU - Hussain, Sarwat
AU - Kao, Kekeletso
AU - Looi, Lai Meng
AU - Pai, Madhukar
AU - Plebani, Mario
AU - Tebeje, Yenew Kebede
AU - Umutesi, Grace
AU - Walia, Kamini
AU - Fleming, Kenneth A.
N1 - Publisher Copyright:
© 2025 Elsevier Ltd
PY - 2025/6/21
Y1 - 2025/6/21
N2 - The Lancet Commission on diagnostics made recommendations for ten topics: national strategy (including national essential diagnostics lists), access in primary care, workforce, regulatory framework, national financing, affordability, appropriate use of technology, needs in conflict or fragile situations, advocacy, and an international alliance with oversight capabilities. Since 2021, progress in these areas has benefitted greatly from the adoption of a World Health Assembly resolution on diagnostics and the work of a broad coalition, as assessed by literature surveys by subject matter experts, quantitative findings (where feasible), and an anonymous survey of knowledgeable and engaged individuals. Greater progress was observed where there was political will and the production of diagnostics coincided with industrial policy goals, also in areas where changing the legal and health policy frameworks was involved. Progress was slower on recommendations with substantial resource implications (eg, labour force, affordability, and diagnostics for conflict situations). It is expected that the Global Diagnostics Coalition will consolidate and accelerate progress.
AB - The Lancet Commission on diagnostics made recommendations for ten topics: national strategy (including national essential diagnostics lists), access in primary care, workforce, regulatory framework, national financing, affordability, appropriate use of technology, needs in conflict or fragile situations, advocacy, and an international alliance with oversight capabilities. Since 2021, progress in these areas has benefitted greatly from the adoption of a World Health Assembly resolution on diagnostics and the work of a broad coalition, as assessed by literature surveys by subject matter experts, quantitative findings (where feasible), and an anonymous survey of knowledgeable and engaged individuals. Greater progress was observed where there was political will and the production of diagnostics coincided with industrial policy goals, also in areas where changing the legal and health policy frameworks was involved. Progress was slower on recommendations with substantial resource implications (eg, labour force, affordability, and diagnostics for conflict situations). It is expected that the Global Diagnostics Coalition will consolidate and accelerate progress.
UR - https://www.scopus.com/pages/publications/105005498406
U2 - 10.1016/S0140-6736(25)00804-9
DO - 10.1016/S0140-6736(25)00804-9
M3 - Review article
AN - SCOPUS:105005498406
SN - 0140-6736
VL - 405
SP - 2241
EP - 2254
JO - The Lancet
JF - The Lancet
IS - 10496
ER -